Clinical trial
Acamprosate Treatment: Mechanisms of Action
NCT00004552 · Yale University, Other · Completed
Key facts
| NCT number | NCT00004552 |
|---|---|
| Title | Acamprosate Treatment: Mechanisms of Action |
| Official title | Etiology and Treatment of Alcohol Dependence |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | acamprosate (Campral) |
| Enrollment | 120 |
| Completion | Dec 1, 2002 |
| First posted | Feb 4, 2000 |
| Last update posted | Jul 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: